Company Analysis

Maravai LifeSciences Holdings, Inc. (MRVI)

Nasdaq: MRVI · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Grade3.8
◀ Past 3.9● Present 4.4▶ Future 2.9

Filings

193 filings since 2017 beside 233 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026
Due nextAccelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends. by Mar 16, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 24, 2026.

Filings a yearinsider forms included
64475054857551
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Oct 27, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Jul 18, 2025.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Mar 18, 2025.SEC letters: 7 in the last 36 months, the newest Feb 20, 2025.A late-filing notice, Form NT 10-K, filed Mar 4, 2025.
Insider forms 233

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 4, 2026 8-K item 9.01 Financial statements and exhibits · Current report
Sep 29, 2026 SCHEDULE 13G Large holder notice
Aug 13, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 7, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Jun 29, 2026 SCHEDULE 13G Large holder notice
Jun 23, 2026 SCHEDULE 13G Large holder notice
Jun 3, 2026 8-K items 1.01, 1.02, 2.03, 7.01, 9.01 Major agreement signed; Major agreement ended; New debt or obligation taken on; Investor disclosure (Regulation FD) · Current report Jun 2, 2026
May 29, 2026 8-K item 5.07 Shareholder vote · Current report May 26, 2026
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 14, 2026 SCHEDULE 13G/A Large holder update, amended
May 12, 2026 SCHEDULE 13G Large holder notice
May 8, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 28, 2026 DEFA14A Extra proxy material
Apr 24, 2026 DEF 14A Proxy statement May 26, 2026
Apr 24, 2026 ARS Annual report to shareholders Dec 31, 2025
Feb 26, 2026 10-K Annual report Dec 31, 2025
Feb 25, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 7, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 31, 2025 SCHEDULE 13G/A Large holder update, amended
Oct 27, 2025 8-K item 5.02 Officer or director change · Current report Oct 21, 2025
Oct 17, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 11, 2025 10-Q Quarterly report Jun 30, 2025
Aug 11, 2025 8-K items 2.02, 2.05, 5.02, 9.01 Results released; Exit or restructuring costs; Officer or director change · Current report Aug 7, 2025
Jul 29, 2025 SCHEDULE 13G/A Large holder update, amended
Jul 18, 2025 8-K items 4.01, 9.01 Auditor change · Current report Jul 16, 2025
Jun 25, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Jun 22, 2025
Jun 9, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Jun 8, 2025
May 29, 2025 SCHEDULE 13G Large holder notice
May 28, 2025 8-K item 5.07 Shareholder vote · Current report May 22, 2025
May 12, 2025 10-Q Quarterly report Mar 31, 2025
May 12, 2025 8-K items 2.02, 9.01 Results released · Current report
May 12, 2025 S-8 Employee stock plan registration
Apr 18, 2025 ARS Annual report to shareholders Dec 31, 2024
40 of 193 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton MRVI · research, not advice